Angiogenesis inhibitor 7

Angiogenesis inhibitor 7 (compound BT2) ia a potent inhibitor of angiogenesis. Angiogenesis inhibitor 7 inhibits ERK phosphorylation, FosB/ΔFosB and VCAM-1 expression[1].

Product Specifications

CAS Number

[922029-50-3]

UNSPSC

12352005

Target

AP-1; ERK

Related Pathways

Immunology/Inflammation; MAPK/ERK Pathway; Stem Cell/Wnt

Applications

COVID-19-immunoregulation

Field of Research

Cancer; Inflammation/Immunology

Smiles

O=C(NC1=CC=C2OC3=C(N(CC)C(C2=C1)=O)C=CC=C3)OCC

Molecular Formula

C18H18N2O4

Molecular Weight

326.35

References & Citations

[1]NewSouth Innovations Pty Limited. Treatment methods comprising administering inhibitors of FosB/ΔFosB expression and/or VCAM-1 expression and/or ERK1/2 phosphorylation. World Intellectual Property Organization, WO2021184059 A1 2021-09-23